The in vitro activities of ticarcillin, piperacillin, clavulanic acid, tazobactam, ticarcillin-clavulanate, and piperacillin-tazobactam against 819 bacterial isolates were compared. The two ,B-lactamase inhibitors, clavulanic acid and tazobactam, had little useful antibacterial activity but enhanced the activities of the penicillins against Il-lactamase-producing strains of Haemophilus influenzae, Branhamella catarrhalis, and methicillin-susceptible Staphylococcus aureus; all strains were susceptible to both combinations. Both enzyme inhibitors also enhanced the activities of the penicillins against most strains of Escherichia coli, Klebsiella spp., Citrobacter diversus, Proteus spp., Providencia spp., and Bacteroides spp. and against occasional strains of Citrobacter freundii, Enterobacter spp., and Serratia marcescens. Clavulanic acid frequently enhanced the activity of ticarcillin against Xanthomonas maltophilia, and tazobactam frequently enhanced the activity of piperacillin against Morganella morganii. Enhancement was observed primarily with strains relatively resistant to the penicillins. In general, clavulanic acid was more effective than tazobactam in enhancing penicillin activity against Klebsiella spp., C. diversus, X. maltophilia, and Bacteroides spp., whereas tazobactam was more effective against Escherichia coli and Proteeae. There was little or no enhancement of activity against Enterococcusfaecalis, Aeromonas hydrophila, Pseudomonas aeruginosa, Pseudomonas cepacia, or Acinetobacter anitratus. Clavulanic acid occasionally antagonized the activity of ticarcillin against ticarcillin-susceptible members of the family Enterobacteriaceae, but those strains were still considered susceptible to the combination. Tazobactam never antagonized the activity of piperacillin. In a direct comparison of the activities of ticarcillin-clavulanate and piperacillin-tazobactam, the two were equally active against H. influenzae, B. catarrhalis, and S. aureus; the latter was more active against E. faecalis. For relatively susceptible strains of members of the family Enterobacteriaceae, neither combination was predictably more active than the other, but relatively resistant strains were generally more susceptible to piperacillin-tazobactam. Piperacillin-tazobactam was more active than ticarcillin-clavulanate against A. hydrophila, P. aeruginosa, and P. cepacia, similar in activity against A. anitratus, and less active against X. maltophilia and Bacteroides spp.
To combat the problem of bacterial resistance to 1-lactam antimicrobial agents, potent new drugs such as the aminothiazolyl cephalosporins, monobactams, and carbapenems which are relatively resistant to inactivation by ,-lactamases have been developed. Another approach to the problem of resistance has been to develop compounds with little intrinsic antibacterial activity but which irreversibly inhibit 1- acillin resistant by virtue of ,B-lactamase production (1-8, 10, 11) .
The purpose of this study was to compare the antibacterial activities of ticarcillin-clavulanate, piperacillin-tazobactam, and the individual agents in those combinations against a diversity of bacterial pathogens. MATERIALS Susceptibility tests. For nonfastidious aerobic and facultatively anaerobic species, MICs were determined by a standardized microdilution method (9) Table 2 . Both penicillins were more active against 3-lactamase-negative strains and P. aeruiginosa typically do not produce enzymes susceptible to these inhibitors or are resistant to penicillin-1-lactamase inhibitor combinations based on impermeability (1, 2, (5) (6) (7) (8) 10) . The quantity and types of enzymes produced by various species and the ability of the drugs to reach their sites of action determine final susceptibilities, which are not always predictable for individual strains of a species (10 
